Substituted xanthines as inhibitors of transient receptor potential cation channel subfamily c, member 5 activity

摘要

The present invention relates to compounds of formula I; a process for their manufacture, pharmaceutical compositions containing them and their use in therapy, particularly in the treatment of conditions having an association with TRPC5 containing ion channels. R1, R2, R3, R4 and R5 have meanings given in the description.